The influenza vaccine innovation system and lessons for PDPs

Human Vaccines & Immunotherapeutics
Farah Huzair

Abstract

As Product Development Partnerships (PDPs) emerge and evolve in response to the need for vaccines, this paper re-examines the oldest and most successful PDP in the vaccine field; that which year after year, produces and reinvents influenza vaccines. This paper describes the influenza vaccine production and innovation system and reviews some of its most recent major innovations. Innovation in this system is a result of collaborative partnerships between various actors from both the public and private sector. It is argued that the influenza vaccine innovation system is a Product Development Partnership (PDP), be it an unconventional one, with a central coordination role allocated to the WHO rather than a private company or charitable/not for profit entity. The unusual structure of this PDP overcomes some of the organizational issues surrounding vaccine research and production faced by other documented PDPs. These are first, the need to coordinate knowledge flow via an effective knowledge broker. Second, the need to build in-house capacity and fund essential research and elements of production where private partners find involvement too risky or costly.

References

Oct 26, 2000·Current Opinion in Microbiology·R Rappuoli
Jun 25, 2003·Drug Discovery Today·Jane Bradbury
May 6, 2005·The New England Journal of Medicine·Michael T Osterholm
Jul 17, 2007·Health Affairs·Charles A GardnerDerek Yach
Apr 8, 2009·Expert Review of Vaccines·Suryaprakash Sambhara, Iain Stephenson
Jan 21, 2010·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Philip D Minor

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bioinformatics in Biomedicine

Bioinformatics in biomedicine incorporates computer science, biology, chemistry, medicine, mathematics and statistics. Discover the latest research on bioinformatics in biomedicine here.

© 2022 Meta ULC. All rights reserved